Literature DB >> 6022771

Ocular melanosis with special reference to chlorpromazine.

M E Cameron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6022771      PMCID： PMC506388          DOI： 10.1136/bjo.51.5.295

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  14 in total

1.  DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.

Authors:  P E FELDMAN; B D FRIERSON
Journal:  Am J Psychiatry       Date:  1964-08       Impact factor: 18.112

2.  OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY.

Authors:  R BOCK; J SWAIN
Journal:  Am J Ophthalmol       Date:  1963-11       Impact factor: 5.258

3.  OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE.

Authors:  R J CAIRNS; H S CAPOORE; I D GREGORY
Journal:  Lancet       Date:  1965-01-30       Impact factor: 79.321

4.  OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY.

Authors:  S L DELONG; B J POLEY; J R MCFARLANE
Journal:  Arch Ophthalmol       Date:  1965-05

5.  A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE.

Authors:  A S ZELICKSON; H C ZELLER
Journal:  JAMA       Date:  1964-04-27       Impact factor: 56.272

6.  Chlorpromazine: ten years' experience.

Authors:  F J AYD
Journal:  JAMA       Date:  1963-04-06       Impact factor: 56.272

7.  [The problem of injuries to the organ of vision caused by protracted & high-dosed largactil therapy; appendix; largactil medication in ophthalmology].

Authors:  H BAUMANN
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1957

8.  OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

Authors:  H E Hobbs; S P Eadie; F Somerville
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638

9.  Pigmentation due to phenothiazines in high and prolonged dosage.

Authors:  A Satanove
Journal:  JAMA       Date:  1965-01-25       Impact factor: 56.272

10.  SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.

Authors:  A C GREINER; K BERRY
Journal:  Can Med Assoc J       Date:  1964-03-14       Impact factor: 8.262
View more
  7 in total

1.  Toxic effects of phenothiazines on the eye.

Authors:  D J Boet
Journal:  Doc Ophthalmol       Date:  1970-07-24       Impact factor: 2.379

2.  The toxicity of diquat.

Authors:  D G Clark; E W Hurst
Journal:  Br J Ind Med       Date:  1970-01

3.  Optic atrophy during chlorpromazine therapy.

Authors:  S M Rab; M N Alam; M D Sadequzzaman
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

4.  Chlorpromazine melanosis.

Authors: 
Journal:  Br Med J       Date:  1967-09-09

5.  Unilateral Conjunctival in situ Squamous Carcinoma with Bilateral Conjunctival Chlorpromazine-Induced Secondary Melanosis Masquerading as in situ and Invasive Melanoma.

Authors:  Katharine S Sears; Ian G Rennie; Hardeep Singh Mudhar
Journal:  Ocul Oncol Pathol       Date:  2015-04-01

6.  Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.

Authors:  S Lal; D Bloom; B Silver; B Desjardins; B Krishnan; J Thavundayil; T Thompson
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

Review 7.  Update on conjunctival pathology.

Authors:  Hardeep Singh Mudhar
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.